Financhill
Buy
56

KPT.TO Quote, Financials, Valuation and Earnings

Last price:
$10.25
Seasonality move :
-1.53%
Day range:
$10.31 - $10.48
52-week range:
$7.54 - $10.50
Dividend yield:
6.89%
P/E ratio:
26.88x
P/S ratio:
1,406.61x
P/B ratio:
1.50x
Volume:
11.7K
Avg. volume:
15.7K
1-year change:
27.59%
Market cap:
$104.6M
Revenue:
--
EPS (TTM):
$0.39

Earnings Data

Next earnings date for KPT.TO
Mar 04
2026
Most recent earnings per share
$0.15
Beat by $0.01
(Nov 13/2025)
Consensus Estimate
$0.14
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KPT.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/04/2026 Q4 $574.2M -- -- $0.25 --
11/13/2025 Q3 $553.7M -- $0.15 $0.14 $0.01
08/13/2025 Q2 $557.9M -- $0.26 $0.12 $0.14
05/14/2025 Q1 $518.2M -- $0.17 $0.09 $0.09
03/05/2025 Q4 $524.2M -- -$0.20 $0.18 -$0.38
11/13/2024 Q3 $512.4M -- $0.21 $0.14 $0.07
08/13/2024 Q2 $492.9M -- $0.12 $0.19 -$0.07
05/21/2024 Q1 $474.4M -- $0.11 -$0.03 $0.14
03/07/2024 Q4 $495.5M -- $0.20 $0.19 $0.02
09/30/2023 Q3 -- -- $0.18 $0.15 $0.04
06/30/2023 Q2 -- -- $0.20 $0.05 $0.15
03/31/2023 Q1 -- -- -$1.07 -$0.09 -$0.99
12/31/2022 Q4 -- -- -$0.10 -$0.04 -$0.06
09/30/2022 Q3 -- -- -$0.63 -$0.14 -$0.49
06/30/2022 Q2 -- -- -$0.40 -$0.21 -$0.19
03/31/2022 Q1 -- -- $0.10 -$0.09 $0.19
12/31/2021 Q4 -- -- $0.35 -$0.04 $0.39
09/30/2021 Q3 -- -- -$0.23 $0.03 -$0.26
06/30/2021 Q2 -- -- -$0.13 $0.06 -$0.19
03/31/2021 Q1 -- -- $0.12 $0.02 $0.10
12/31/2020 Q4 -- -- -$0.44 $0.13 -$0.57
09/30/2020 Q3 -- -- $0.08 $0.26 -$0.18
06/30/2020 Q2 -- -- -$0.01 $0.20 -$0.21
03/31/2020 Q1 -- -- $0.18 $0.17 $0.01
12/31/2019 Q4 -- -- -$0.17 $0.19 -$0.36
09/30/2019 Q3 -- -- -$0.04 $0.11 -$0.15
06/30/2019 Q2 -- -- $0.04 $0.03 $0.01
03/31/2019 Q1 -- -- -$0.25 -$0.06 -$0.19
12/31/2018 Q4 -- -- -$0.03 $0.04 -$0.08
09/30/2018 Q3 -- -- $0.06 $0.08 -$0.01
06/30/2018 Q2 -- -- $0.03 $0.09 -$0.06
03/31/2018 Q1 -- -- $0.03 $0.05 -$0.03
12/31/2017 Q4 -- -- -$0.16 $0.21 -$0.36
09/30/2017 Q3 -- -- $0.26 $0.24 $0.02
06/30/2017 Q2 -- -- $0.15 $0.18 -$0.03
03/31/2017 Q1 -- -- -- $0.15 --
12/31/2016 Q4 -- -- -$0.59 $0.25 -$0.84

KP Tissue, Inc. Earnings Questions

  • How Much did KP Tissue, Inc. Generate in Revenue Last Quarter?

    KP Tissue, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did KP Tissue, Inc. Beat Earnings Last Quarter?

    KP Tissue, Inc. announced earnings per share of $0.15 which represents a beat of analyst forecast a $0.14 per share.

  • Is KP Tissue, Inc. Profitable?

    KP Tissue, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for KP Tissue, Inc. EPS Next Year?

    KP Tissue, Inc.'s earnings are forecast to grow from $0.24 per share to $0.78 per share next year representing an increase of 187.03%.

  • When is KP Tissue, Inc.'s Earnings Date?

    KP Tissue, Inc.'s next earnings date is March 4, 2026.

Related Companies

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock